Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies
Holly K. Koblish(Wilmington University), Peggy Scherle(Experimental Station)
Cited by 53
Related Papers
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
|Bioorganic & Medicinal Chemistry Letters|1998|406
Inhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy
|The Journal of Immunology|1998|294
Inhibition of MAP Kinase Kinase Prevents Cytokine and Prostaglandin E2 Production in Lipopolysaccharide-Stimulated Monocytes
|The Journal of Immunology|1998|257
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α
|Proceedings of the National Academy of Sciences|2001|139